Qinecsa Solutions

We are Qinecsa. Trusted partners to global life science companies. We bring together comprehensive safety technology products and scientific expertise to connect life science companies to the right safety solutions. Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. We pride ourselves on offering industry-leading pharmacovigilance technology products to support the pharmacovigilance landscape of tomorrow unlocking the power of end-to-end solutions: Reportum platform Our automated case intake and follow up platform, Reportum, provides a centralized solution for multi-lingual data capture across all intake sources to increase efficiencies and standardize safety data intake and management. HALOPV Revolutionary platform for managing all drug safety processes comprehensively, from ICSR, submissions, Aggregates, signal, risk management, PSMF, and beyond. Vigilance Workbench (CVW) platform Our signal detection & management platform, the Commonwealth Vigilance Workbench (CVW), spans the full spectrum of the signal management process to ensure no signals are missed and important signals are prioritized. Working with life science companies we drive progress to continue protecting lives.

bristol myers squibb uk & ireland

Bristol Myers Squibb is a differentiated company, led by our revolutionary BioPharma strategy that combines the reach and resources of a major pharmaceutical firm with the entrepreneurial flair and swiftness of a biotech business. We strive to provide advanced medications for people struggling from life-threatening illnesses each and every day. Each day, our employees around the world work together for patients - it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis, and specialty medicines. Through our Research & Development organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work. As global citizens, we operate in a responsible and sustainable manner and search for ways to give back. Through the Bristol Myers Squibb Foundation, we promote health equity and attempt to improve health outcomes of those disproportionately affected by severe illnesses, bringing new hope to some of the most vulnerable people across the globe.

msd in the uk

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd-UK.com and connect with us on Twitter, Facebook and Instagram - @MSDintheUK - or on YouTube.

Accord Healthcare

Accord Healthcare is an award-winning pharmaceutical company driven to thinking differently so that more patients around the world have access to the essential and affordable medicines that they need. With operations in over 85 countries worldwide, and a pan-European footprint of more than 45 countries, Accord Healthcare develops, manufactures and distributes affordable medicines, and has one of the most active launch programmes in the European pharmaceutical sector. Life at Accord Healthcare is fast-paced and agile. We drive for results and are committed to delivering the highest possible standards because we understand that everything we do has an impact for our customers and for the patients that receive our medicines. We always strive to make it better by challenging ourselves to think differently and to deliver more every day. Whether it is product development, improving our systems and operations or building patient-focused added value services, we realise that each innovation could improve the lives of the patients who receive our medication. Living our purpose and achieving our goals means we can deliver more vital, affordable medicines to national health systems and the patients who need them most. At Accord we recognise that developing the skills and capabilities of our people is essential to the achievement of our organisation goals and we support each and every employee in doing so.

Tilray Brands, Inc.

Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages. Content in Canadian communications may relate to cannabis produced in accordance with Health Canada Licences by Aphria Inc.